ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
542 |
253K |
22 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
542
|
253K
|
22
|
|
ASX - By Stock
|
NEU |
Re:
What has changed?
|
|
hottod
|
33 |
20K |
80 |
14/09/24 |
14/09/24 |
ASX - By Stock
|
33
|
20K
|
80
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
75 |
13/09/24 |
13/09/24 |
ASX - By Stock
|
12K
|
5.5M
|
75
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
420K |
46 |
11/09/24 |
11/09/24 |
ASX - By Stock
|
1.0K
|
420K
|
46
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
hottod
|
1.9K |
1.0M |
55 |
09/09/24 |
09/09/24 |
Charts
|
1.9K
|
1.0M
|
55
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
hottod
|
1.9K |
1.0M |
35 |
09/09/24 |
09/09/24 |
Charts
|
1.9K
|
1.0M
|
35
|
|
Charts
|
NEU |
Re:
NEU chart
|
|
hottod
|
1.9K |
1.0M |
103 |
09/09/24 |
09/09/24 |
Charts
|
1.9K
|
1.0M
|
103
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
30 |
09/09/24 |
09/09/24 |
ASX - By Stock
|
12K
|
5.5M
|
30
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
16 |
08/09/24 |
08/09/24 |
ASX - By Stock
|
12K
|
5.5M
|
16
|
|
ASX - By Stock
|
PYC |
Re:
A clue to a deal
|
|
hottod
|
15 |
8.6K |
22 |
07/09/24 |
07/09/24 |
ASX - By Stock
|
15
|
8.6K
|
22
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
39 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
107
|
37K
|
39
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
24 |
06/09/24 |
06/09/24 |
ASX - By Stock
|
12K
|
5.5M
|
24
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
18 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
12K
|
5.5M
|
18
|
|
ASX - By Stock
|
PYC |
Re:
A clue to a deal
|
|
hottod
|
15 |
8.6K |
27 |
03/09/24 |
03/09/24 |
ASX - By Stock
|
15
|
8.6K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
Rare paediatric disease priority review
|
|
hottod
|
32 |
22K |
56 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
32
|
22K
|
56
|
|
ASX - By Stock
|
PYC |
Re:
A clue to a deal
|
|
hottod
|
15 |
8.6K |
27 |
01/09/24 |
01/09/24 |
ASX - By Stock
|
15
|
8.6K
|
27
|
|
ASX - By Stock
|
PYC |
Re:
Ann: Q3 2024 Investor Webinar Presentation
|
|
hottod
|
17 |
7.2K |
33 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
17
|
7.2K
|
33
|
|
ASX - By Stock
|
PYC |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation to PYC-001
|
|
hottod
|
15 |
7.1K |
34 |
30/08/24 |
30/08/24 |
ASX - By Stock
|
15
|
7.1K
|
34
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
15 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
107
|
37K
|
15
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
13 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
107
|
37K
|
13
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
27 |
29/08/24 |
29/08/24 |
ASX - By Stock
|
107
|
37K
|
27
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
36 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
107
|
37K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
PHASE2 PRADER WILLI SYNDROME START !!!!
|
|
hottod
|
42 |
32K |
23 |
28/08/24 |
28/08/24 |
ASX - By Stock
|
42
|
32K
|
23
|
|
ASX - By Stock
|
PNV |
Re:
The Clinicians Speak
|
|
hottod
|
1.0K |
420K |
36 |
27/08/24 |
27/08/24 |
ASX - By Stock
|
1.0K
|
420K
|
36
|
|
ASX - By Stock
|
NEU |
Re:
Acadia
|
|
hottod
|
867 |
410K |
53 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
867
|
410K
|
53
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
44 |
26/08/24 |
26/08/24 |
ASX - By Stock
|
107
|
37K
|
44
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
40 |
25/08/24 |
25/08/24 |
ASX - By Stock
|
107
|
37K
|
40
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
15 |
24/08/24 |
24/08/24 |
ASX - By Stock
|
107
|
37K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
66 |
24/08/24 |
24/08/24 |
ASX - By Stock
|
12K
|
5.5M
|
66
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY24 Results Presentation
|
|
hottod
|
107 |
37K |
16 |
24/08/24 |
24/08/24 |
ASX - By Stock
|
107
|
37K
|
16
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
32 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
12K
|
5.5M
|
32
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Appendix 4E and FY24 Financial Statements
|
|
hottod
|
41 |
14K |
27 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
41
|
14K
|
27
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
hottod
|
80 |
34K |
24 |
23/08/24 |
23/08/24 |
ASX - By Stock
|
80
|
34K
|
24
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
hottod
|
80 |
34K |
40 |
22/08/24 |
22/08/24 |
ASX - By Stock
|
80
|
34K
|
40
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
hottod
|
80 |
34K |
28 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
80
|
34K
|
28
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
hottod
|
80 |
34K |
67 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
80
|
34K
|
67
|
|
ASX - By Stock
|
NEU |
Re:
The Whens and Whys of Top Biotech M&A Deals
|
|
hottod
|
80 |
34K |
48 |
21/08/24 |
21/08/24 |
ASX - By Stock
|
80
|
34K
|
48
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor roadshow presentation, 19 August 2024
|
|
hottod
|
35 |
17K |
14 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
35
|
17K
|
14
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor roadshow presentation, 19 August 2024
|
|
hottod
|
35 |
17K |
78 |
20/08/24 |
20/08/24 |
ASX - By Stock
|
35
|
17K
|
78
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Investor roadshow presentation, 19 August 2024
|
|
hottod
|
35 |
17K |
65 |
19/08/24 |
19/08/24 |
ASX - By Stock
|
35
|
17K
|
65
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
720K |
2 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.3K
|
720K
|
2
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
720K |
4 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.3K
|
720K
|
4
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
720K |
57 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
1.3K
|
720K
|
57
|
|
ASX - By Stock
|
PYC |
Re:
PYC - General Discussion
|
|
hottod
|
542 |
253K |
25 |
16/08/24 |
16/08/24 |
ASX - By Stock
|
542
|
253K
|
25
|
|
ASX - By Stock
|
NEU |
Re:
Neuren Media and Analyst Coverage
|
|
hottod
|
1.3K |
720K |
60 |
15/08/24 |
15/08/24 |
ASX - By Stock
|
1.3K
|
720K
|
60
|
|
ASX - By Stock
|
NEU |
Re:
Share Price
|
|
hottod
|
12K |
5.5M |
72 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
12K
|
5.5M
|
72
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
hottod
|
87 |
45K |
47 |
14/08/24 |
14/08/24 |
ASX - By Stock
|
87
|
45K
|
47
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Phase 2 trial shows significant improvements in Angelman
|
|
hottod
|
87 |
45K |
103 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
87
|
45K
|
103
|
|
ASX - By Stock
|
OPT |
Biosimilar Update
|
|
hottod
|
11 |
3.2K |
15 |
13/08/24 |
13/08/24 |
ASX - By Stock
|
11
|
3.2K
|
15
|
|
ASX - By Stock
|
NEU |
Re:
NEU is materially undervalued
|
|
hottod
|
59 |
29K |
38 |
12/08/24 |
12/08/24 |
ASX - By Stock
|
59
|
29K
|
38
|
|